"We provide help and inspire hope to those affected by cancer through high quality, advanced oncology and hematology cancer treatments and leading-edge technology."

During the past decade, Northwest Georgia Oncology Centers, PC conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 53 clinical trials were completed, i.e. on average, 89.8% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 29 clinical trials were completed. i.e. 138.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Georgia Oncology Centers, PC" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Accelerated Community Oncology Research Network" with 7 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored, "Celgene" with 6 trials sponsored and "Genentech, Inc." with 6 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Georgia Oncology Centers, PC" #1 collaborator was "Genentech, Inc." with 7 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Eisai Inc." with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Georgia Oncology Centers, PC" are "Breast Cancer" (13 trials), "Non-Small Cell Lung Cancer" (6 trials), "Metastatic Breast Cancer" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials) and "Non-small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Northwest Georgia Oncology Centers, PC" in a lesser frequency.

Most popular intervention types in "Northwest Georgia Oncology Centers, PC" are "Drug" (107 trials), "Biological" (11 trials), "Other" (7 trials), "Dietary Supplement" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Atezolizumab" (11 trials), "Carboplatin" (10 trials), "Docetaxel" (10 trials) and "Paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Georgia Oncology Centers, PC" are 93 trials for "All" genders, 17 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Georgia Oncology Centers, PC". undefined are not yet recruiting, 15 are recruiting, 23 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 58 completed trials in Northwest Georgia Oncology Centers, PC, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Georgia Oncology Centers, PC, 9 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Northwest Georgia Oncology Centers, PC has several departments that took part in Clinical trials: "Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute" - 2 trials